课题基金 / 基金详情

Developing Process-Specific Verbal Memory Interventions for Veterans with TBI

Developing Process-Specific Verbal Memory Interventions for Veterans with TBI
为患有 TBI 的退伍军人制定特定过程的言语记忆干预措施
批准号:
8986675
负责人:
RUSSELL M BAUER
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-01-01 至 2016-12-31

项目摘要

项目成果

RUSSELL M BAUER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Background and Purpose: Traumatic brain injury (TBI) has been described as a "signature injury" of the OIF-OEF-OND combat experience. Chronic memory deficits due to problems in memory encoding, consolidation, or retrieval, are often seen after moderate-severe TBI (M- STBI) and may pose barriers to community re-entry, retraining, and rehabilitation. Studies have demonstrated some efficacy in memory rehabilitation using cognitive treatments such as memory strategy training, errorless learning techniques, retrieval practice, and other methods. However, some patients do not benefit from such interventions, while others minimally improve. No prior group study has attempted to match the Veteran's specific information-processing deficit with a memory rehabilitation therapy targeted to their specific problem (patient-treatment matching), though such an approach should produce the best results. We propose to develop and test three memory therapies, each designed to foster improvement in a particular stage of memory processing. Veterans will then be classified by their primary locus of impairment and will participate in (a) a treatment matched to their deficit, and (b) a mismatched treatment. It is predicted that Veteran participants will show greater benefit from the matched treatment. If successful, this research could guide decision-making regarding the most efficacious approaches to alleviating disabling memory deficits in Veterans with M-STBI. Procedures: The proposed research takes place in three phases. In Phase 1, three memory therapies (memory strategy training, errorless learning, and retrieval practice) will be formalized through the development of a treatment manual. Therapists will be trained to provide these treatments with high fidelity, and their adherence to treatment regimens will be measured. In Phase 2, Veterans with chronic memory deficits from M-STBI will be evaluated with neuropsychological (NP) and neuroimaging (MRI) probes. The NP probes will allow us to classify participants into three groups, according to the primary locus of their memory deficit in encoding, consolidation, or retrieval. MRI sequences enable discovery of structural (morphometric and diffusion imaging) and functional (resting state functional connectivity) biomarkers of this classification, for use i a later trial evaluating the neural basis of treatment improvement. In Phase 3, Veteran participants will undergo treatment with two therapies, one matched to their deficit, the other mismatched. Treatment effect will be measured by assessing change on NP measures and on real-life functional measures and quality of life. Key Questions: Our primary goal is to develop and test the efficacy of three process-specific memory interventions in a heterogeneous population of Veterans with chronic memory impairment after M-STBI. We aim to learn whether improved efficacy results from appropriate patient-treatment matching. We also hope to refine a classification system that reliably identifies encoding, consolidation, and retrieval deficits in or participants, and to identify specific structural and functional brain biomarkers of this classification scheme. For our long term goal, we aim to maximize the efficacy of memory improvement therapies for alleviating memory impairment after acquired brain injury, and to use both NP and brain imaging biomarkers in better understanding mechanisms of change resulting from rehabilitative intervention. This knowledge will enhance discovery of best practices for treating debilitating memory dysfunction and maximizing functional recovery after injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Brain Rehabilitation Research Center
  • 批准号:
    10268968
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    RUSSELL M BAUER
  • 依托单位:
Brain Rehabilitation Research Center
  • 批准号:
    9910074
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    RUSSELL M BAUER
  • 依托单位:
National Neuropsychological Network (NNN)
National Neuropsychological Network (NNN)
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: